EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 233 filers reported holding EMERGENT BIOSOLUTIONS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $296,126 | +149.3% | 87,096 | +439.0% | 0.01% | +175.0% |
| Q2 2023 | $118,776 | -5.4% | 16,160 | +52.1% | 0.00% | -50.0% |
| Q4 2022 | $125,505 | -61.7% | 10,627 | +40.9% | 0.01% | -46.7% |
| Q4 2021 | $328,000 | -51.1% | 7,543 | +0.7% | 0.02% | -48.3% |
| Q4 2020 | $671,000 | -60.8% | 7,490 | -54.8% | 0.03% | -63.8% |
| Q3 2020 | $1,711,000 | +388.9% | 16,560 | +155.5% | 0.08% | +433.3% |
| Q4 2019 | $350,000 | +65.1% | 6,481 | +54.3% | 0.02% | +15.4% |
| Q1 2019 | $212,000 | – | 4,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zebra Capital Management LLC | 22,111 | $908,000 | 2.08% |
| Global Alpha Capital Management Ltd. | 460,530 | $18,909,000 | 1.62% |
| AIMZ Investment Advisors, LLC | 70,625 | $2,900,000 | 1.19% |
| Bridge City Capital, LLC | 39,835 | $1,636,000 | 0.76% |
| PALISADE CAPITAL MANAGEMENT, LP | 560,409 | $23,010,000 | 0.53% |
| EARNEST PARTNERS LLC | 2,071,376 | $85,051,000 | 0.50% |
| RICE HALL JAMES & ASSOCIATES, LLC | 302,721 | $12,430,000 | 0.50% |
| SummerHaven Investment Management, LLC | 14,476 | $594,000 | 0.34% |
| Ridgewood Investments LLC | 10,004 | $411,000 | 0.27% |
| AtonRa Partners | 11,505 | $472,000 | 0.26% |